Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Discover whether stocks or bonds are better for achieving financial freedom. Start making smarter investment decisions today.
26,067 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Micron Technology unveiled long-term contracts totaling about $100 billion in minimum revenue through 2030, sending s...
Is IonQ stock overvalued right? This in-depth guide breaks down the technology, market timing, and financials to help...
As 2026 brings higher IRMAA thresholds, retirees near the line must plan for steeper Medicare costs. This report expl...
Analysts estimate the Iran war has added roughly $1,000 to the typical American household’s costs, driven by higher f...
Trump allies are renewing efforts to reshape the Federal Reserve after a Supreme Court decision, targeting governors ...
Ford is recalling 177,000 vehicles after regulators flagged wiper and drivetrain faults. The recall covers certain Mu...
A Duke University professor warns that lidar sensors in America's self-driving fleets are vulnerable to spoofing and ...
Adobe has pulled back about 40% from its peak, but new AI-driven products and expanding ARR are reinvigorating the bu...
A disciplined investment approach blends steady dividend payers with selective high-yield assets to produce durable i...
BNY Mellon posted stronger margins and revenue growth than State Street in Q1 2026, signaling a platform-led edge as ...
Nvidia is delivering a hopeful signal for investors as its expanding enterprise AI software platform intrigues buyers...